Fortune 500 Medical Services Provider Partners with Quantzig to Optimize Decisions and Develop Insights for Value Assessments Using RWE Analytics
Quantzig, a leader in delivering scalable analytics solutions and data science services, today announced the completion of its real world evidence analytics engagement.
Quantzig, a leader in delivering scalable analytics solutions and data science services, today announced the completion of its real world evidence analytics engagement.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200710005095/en/
Connect with us and get attractive discounts on long term engagements. (Graphic: Business Wire)
“Our analytics skills combined with technological prowess can help you identify the right development paths- those that deliver maximum value with the optimal balance of risk, speed, and efficiency,” says a real world evidence analytics expert at Quantzig.
Partnering with us can help drive maximum returns from your analytical investments. Request a FREE proposal to get started.
The dynamism in the healthcare market has prompted business leaders and key decision-makers to understand the changing requirements and regulatory policies in this sector. As such, healthcare organizations are now looking to leverage advanced analytics to interpret data from patient records, clinical trials, and treatment outcomes to gain a better understanding of disease progression patterns, resource usage, treatment pathways, and the factors that determine the outcome.
Real World Evidence Analytics Engagement Summary
The client- a leading healthcare industry player based out of the United States, approached Quantzig looking to leverage RWE analytics to improve the clinical development planning process and develop insights for value assessments of treatments.
To help the client tackle their challenges, we adopted a comprehensive three-pronged approach that revolved around the use of real-world analytics, text mining, clinical trial analysis, and real-world data modeling to deliver measurable results.
Phase 1 – Data acquisition and integration
Phase 2 – Treatment pathway analysis
Phase 3 – Data dashboarding and reporting
Quantzig is at the forefront of enabling data-driven decision making for healthcare and life sciences companies to optimize outcomes. Speak to our experts to learn more about our capabilities.
Value Delivered
- Analyzed treatment patterns and their outcomes
- Developed a real-world strategy to optimize healthcare outcomes
- Categorized patient cohorts based on drug usage and treatment pathways
We offer cutting-edge real-world evidence analytics solutions to help healthcare organizations improve commercial success using real world insights. Collaborating with us can help you make the most of the data at hand by applying advanced data modeling techniques and solutions designed and custom-built to suit your needs. Book a FREE Demo to learn more about our proprietary analytics platforms and real-world data analytics capabilities.
Additional Resources:
- Pharmaceutical Drug Development Firm Enhanced Disease Taxonomy & Clinical Trial Outcomes With Real World Evidence Analytics
- Real World Evidence Analytics Solutions Helped A German Pharmaceutical Company Reduce Sampling Costs and Increase Sales By 17%
- Real World Evidence Analytics Solutions Helped a Pharma Company Improve Drug Efficacy and Increase Market Share By 3x
About Quantzig
Quantzig is a global analytics and advisory firm with offices in the US, UK, Canada, China, and India. For more than 15 years, we have assisted our clients across the globe with end-to-end data modeling capabilities to leverage analytics for prudent decision making. Today, our firm consists of 120+ clients, including 45 Fortune 500 companies. For more information on our engagement policies and pricing plans, visit: https://www.quantzig.com/request-for-proposal
View source version on businesswire.com: https://www.businesswire.com/news/home/20200710005095/en/